Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rivaroxaban”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT04067505
What this trial is testing

Rivaroxaban for the Prevention of Deep Vein Thrombosis in Patients With Left Iliac Vein Compression - The PLICTS Study

Who this might be right for
May-Thurner Syndrome
Second Affiliated Hospital, Zhejiang University, School of Medicine 224
Large-scale testing (Phase 3)Study completedNCT03969953
What this trial is testing

Treatment of Cardiovascular Disease With Low Dose Rivaroxaban in Advanced Chronic Kidney Disease

Who this might be right for
Chronic Kidney DiseasesDialysis-dependent Kidney FailureCardiovascular Disease
The George Institute 1,753
Not applicableWithdrawnNCT02539953
What this trial is testing

Ambulatory Blood Pressure Monitoring in Rivaroxaban Therapy

Who this might be right for
Hypotension
King's College Hospital NHS Trust
Large-scale testing (Phase 3)Looking for participantsNCT05410275
What this trial is testing

Chronic Anticoagulation With a Reduced Dose Regimen of Rivaroxaban in End-stage Renal Disease Patients

Who this might be right for
Chronic Hemodialysis Patients
University Hospital, Tours 10
Post-approval studies (Phase 4)Study completedNCT07618988
What this trial is testing

Rivaroxaban in Pediatric Patients With DVT

Who this might be right for
Pediatric Venous Thromboembolism
Ain Shams University 60
Post-approval studies (Phase 4)Looking for participantsNCT06013020
What this trial is testing

Century Clot-Guided Prophylactic Rivaroxaban for Post STEMI Complicating Left Ventricular Thrombus

Who this might be right for
STEMI - ST Elevation Myocardial Infarction
Zunyi Medical College 374
Large-scale testing (Phase 3)Looking for participantsNCT06195540
What this trial is testing

RIVAroxaban Versus Low-molecular Weight Heparin in Patients With Lower Limb Trauma Requiring Brace or CASTing

Who this might be right for
Venous ThromboembolismDeep Vein ThrombosisPulmonary Embolism+3 more
University Hospital, Angers 1,424
Not applicableNot Yet RecruitingNCT06953778
What this trial is testing

The Effectiveness of Patch-Based Screening for Pre-Symptomatic Atrial Fibrillation to Improve Patient Outcome

Who this might be right for
Atrial Fibrillation
VA Office of Research and Development 24,060
Post-approval studies (Phase 4)UnknownNCT05303818
What this trial is testing

Chemoprophylaxis With Rivaroxaban for Lower Limb Deep Vein Thrombosis in Colorectal Cancer

Who this might be right for
Deep Venous ThrombosisColonic Cancer
Hospital do Servidor Publico Estadual 68
Large-scale testing (Phase 3)Study completedNCT01674647
What this trial is testing

Explore the Efficacy and Safety of Once-daily Oral Rivaroxaban for the Prevention of Cardiovascular Events in Subjects With Nonvalvular Atrial Fibrillation Scheduled for Cardioversion

Who this might be right for
Atrial Fibrillation
Bayer 1,504
Early research (Phase 1)Study completedNCT04767776
What this trial is testing

Non Inferiority Study of a Reduced Dose of Activated Charcoal on Rivaroxaban Pharmacokinetics.

Who this might be right for
Healthy
Centre Hospitalier Universitaire de Saint Etienne 12
Post-approval studies (Phase 4)Study completedNCT03413618
What this trial is testing

Rivaroxaban With Diosmin in Long-term Treatment of Deep Vein Thrombosis

Who this might be right for
Deep Vein ThrombosisPostthrombotic Syndrome
Pirogov Russian National Research Medical University 90
Testing effectiveness (Phase 2)Study completedNCT00402597
What this trial is testing

Rivaroxaban in Combination With Aspirin Alone or With Aspirin and a Thienopyridine in Patients With Acute Coronary Syndromes (The ATLAS ACS TIMI 46 Trial)

Who this might be right for
Acute Coronary Syndrome
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 3,490
Post-approval studies (Phase 4)UnknownNCT03490994
What this trial is testing

Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)

Who this might be right for
Acute Heart Failure
Yonsei University 150
Large-scale testing (Phase 3)UnknownNCT05700266
What this trial is testing

Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis

Who this might be right for
Ischemic StrokeIntracranial AtherosclerosisStenosis
The First Affiliated Hospital with Nanjing Medical University 1,180
Not applicableStudy completedNCT01598051
What this trial is testing

Xarelto [SPAF-QOL] Post-marketing Surveillance in Japan

Who this might be right for
Non-valvular Atrial Fibrillation (NVAF)
Bayer 741
Not applicableStudy completedNCT01722786
What this trial is testing

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists

Who this might be right for
Severe BleedingUrgent Surgery
Cardioangiologisches Centrum Bethanien 272
Not applicableLooking for participantsNCT06957366
What this trial is testing

Perioperative Anticoagulant Use for Surgery Evaluation -2 (PAUSE-2) Study Patients Receiving a Direct Oral Anticoagulant (DOACs-Dabigatran, Rivaroxaban, Apixaban or Edoxaban) and Needing Elective High-Bleed-Risk Surgery or an Invasive Procedure

Who this might be right for
Atrial Fibrillation (AF)VTE
McMaster University 920
Large-scale testing (Phase 3)UnknownNCT06531122
What this trial is testing

Rivaroxaban Versus Apixaban in Cerebral Venous Thrombosis

Who this might be right for
Cerebral Venous Thrombosis
Kafrelsheikh University 200
Not applicableStudy completedNCT07774273
What this trial is testing

Bleeding Risk With Apixaban Versus Rivaroxaban in Acute Pulmonary Embolism

Who this might be right for
Pulmonary Embolism AcuteVenous Thromboembolism (VTE)
Combined military hospital lahore 540
Next Page